Background
• Worldwide, the Short Synacthen Test (SST) is the most frequently performed diagnostic test for adrenal insufficiency (AI) in children. 1 • Diagnostic cut-offs for peak plasma cortisol may be difficult to determine due to:
• Non-specific clinical features of AI. 2 • Increased sensitivity and specificity of different cortisol assays. 3
• "Borderline" results may be interpreted and managed variably by different clinicians. 4
Methods
• Dataset: 433 SSTs from 2014-2017
• "Borderline" cases defined as a peak cortisol following synacthen stimulation of >300 but <450 nmol/L.
• Cortisol assay: Abbott Architect chemiluminescent immunoassay (CVs <5%).
• Data extracted:
• SST patient demographics • SST dose: 1 mcg low-dose (LD) or 250 mcg standard dose (SD) • SST indication: weaning from steroids, clinically suspected AI or pituitary dysfunction • SST result categorised by:
• Pass >449 nmol/L • Fail <300 nmol/L • Borderline: 300-349, 350-399, 400-449
• Physician management following SST result
Results
• SSTs categorised as "borderline": 74/433 (17.1%)
• Age distribution: 0-1yr: 8%, 2-5yrs: 11%, 6-10yrs: 27%, 11-15yrs: 39%, 16+yrs: 15% • SD: 60.8%, LD: 31.1%, dose unknown: 8.1%
• Number of borderline results remained similar over study period despite increasing numbers of SSTs ( fig 1) • There was an increasing trend towards using SD over LD SST (47.4% SD 2014-15 vs 87.5% SD 2016-17)
• Following SST physician management strategies differed depending on:
• The dose of synacthen used for the test • Which category of "borderline" the result fell into • Whether the child was already on replacement steroids • The index of suspicion for AI
• 23% of 'borderline' cases were managed with "sick day rule" steroid cover only (59% previously on daily oral steroid, 41% not)
• Steroid dose was more likely to be weaned after standard dose SST (33.3%) compared to low-dose SST (17.4%) (fig 2a+b) 
Discussion
• Our local practice has changed -more tests are being performed, a greater proportion use the standard dose, but the numbers of results between 300-449 nmol/L has remained static.
• There is variation in the interpretation of an SST depending on the indication of the test, dose of Synacthen used and whether the patient is already on steroids.
• Provision of 'sick day rules' for children with "borderline" results may provide a more pragmatic management approach but the efficacy & safety of this approach requires further study.
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To examine cases with borderline peak plasma cortisol following SST to identify aetiological links and common management strategies. • 83% of SST performed in patients not already on daily oral steroids were done for clinical suspicion of AI. Following a 'borderline' result 29% of these were commenced on steroids (daily replacement or sick days rules only).
• Overall 6 new cases of AI were identified from 'borderline' cortisol results over 3 years (8.1% of borderline SSTs) 
